Suresh G. Nair
Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Suresh G. Nair

Hematology | Oncology
Lehigh Valley Health Network
LVH Hematology Oncology-1240 Cedar Crest
1240 S Cedar Crest Blvd, Suite 401, 
Allentown, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
Lehigh Valley Health Network
LVH Hematology Oncology-1240 Cedar Crest
1240 S Cedar Crest Blvd, Suite 401, 
Allentown, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Philosophy of care | Personalized care starts during my first meeting with a patient and family. That's when I get to know the patient as completely as possible. I want to know about the patient's concerns, values and support system so I can provide care that is specific to him or her. | Also, I am a member of the skin and soft tissue cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. | Why I entered medicine | When I was young, I didn't like seeing doctors. It created a lot of anxiety for me. Now that I'm older, I can relate to the way people feel, especially when they're coping with the emotions caused by a serious condition like cancer. My grandmother died of uterine cancer in the 1960s. During her battle, I felt helpless. That is what attracted me to cancer research. Now I see the amazing progress we are making through cancer research. | Community involvement | I served on the state board of the American Cancer Society. Today, I take more of a grassroots approach to offer my support. I participate in events, such as 5K runs, that benefit charities.

Dr. Nair is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Melanoma, Adult Soft Tissue Sarcoma, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Jefferson Medical College, Doctor Of Medicine (MD), 1984
Residency
Internal Medicine, Geisinger Community Medical Center, Scranton, PA- 1986, 1987
Specialties
Hematology
Oncology
Licenses
Internal Medicine in PA
Board Certifications
American Board Of Internal Medicine - Medical Oncology
American Board Of Internal Medicine - Internal Medicine
Fellowships
Hematology & Oncology, University of Pittsburgh, Pittsburgh, PA- 1988, 1989, 1990
Hospital Affiliations
Lehigh Valley Hospital - Pocono
Lehigh Valley Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

LVH Hematology Oncology-1240 Cedar Crest
1240 S Cedar Crest Blvd, Suite 401, Allentown, PA 18103
Call: 610-402-7880

Additional Areas of Focus

Dr. Nair has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Enrollment Status: Recruiting
Publish Date: January 12, 2026
Intervention Type: Drug
Study Drugs: Vismodegib, GSK2256098, Capivasertib, Abemaciclib
Study Phase: Phase 2
A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drugs: Paclitaxel, Veliparib, Carboplatin
Study Phase: Phase 3
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 1b Study to Evaluate the Safety and Clinical Activity of AB122 in Biomarker-Selected Participants With Advanced Solid Tumors
A Phase 1b Study to Evaluate the Safety and Clinical Activity of AB122 in Biomarker-Selected Participants With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
Enrollment Status: Unknown
Publish Date: February 02, 2024
Intervention Type: Procedure, Other, Drug
Study Phase: Phase 2/Phase 3
A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)
A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) With Pembrolizumab (KEYTRUDA®) for Recurrent Glioblastoma or Gliosarcoma (CAPTIVE/KEYNOTE-192)
Enrollment Status: Completed
Publish Date: July 15, 2021
Intervention Type: Biological
Study Drugs: DNX-2401 Adeno-Associated Oncolytic Virus Delta-24 Vaccine, Pembrolizumab
Study Phase: Phase 2
View 5 Less Clinical Trials

2 Total Publications

Anesthetic Challenges and Perioperative Factors Affecting Delayed Graft Function in Robotic-Assisted Kidney Transplant: A Review of a Single-Center Experience of 100 Cases.
Anesthetic Challenges and Perioperative Factors Affecting Delayed Graft Function in Robotic-Assisted Kidney Transplant: A Review of a Single-Center Experience of 100 Cases.
Journal: Cureus
Published: August 24, 2022
View All 2 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Naomi B. Haas
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Naomi B. Haas
Oncology

Abramson Cancer Center Perelman 2nd Floor West

3400 Civic Center Boulevard, West Pavilion, 2nd Floor, 
Philadelphia, PA 
 (46.2 miles away)
215-615-5858
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Naomi Haas is an Oncologist in Philadelphia, Pennsylvania. Dr. Haas is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Renal Cell Carcinoma (RCC). Dr. Haas is currently accepting new patients.

Maged F. Khalil
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Maged F. Khalil
Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Maged F. Khalil
Hematology | Oncology

LVH Hematology Oncology-1240 Cedar Crest

1240 S Cedar Crest Blvd, Suite 401, 
Allentown, PA 
 (0.1 miles away)
610-402-7880
Languages Spoken:
English, Arabic
See accepted insurances

Philosophy of care | I am a member of the GI cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. Dr. Khalil is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, Anal Cancer, and Bone Marrow Aspiration.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Daniel M. Geynisman
Oncology | Transplant Surgery
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Daniel M. Geynisman
Oncology | Transplant Surgery

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
 (43.4 miles away)
215-707-5030
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Geynisman is an Oncologist and a Transplant Surgeon in Philadelphia, Pennsylvania. Dr. Geynisman is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Orchiectomy.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nair's expertise for a condition
ConditionClose
    • Distinguished
    • Adult Soft Tissue Sarcoma
      Dr. Nair is
      Distinguished
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Alveolar Soft Part Sarcoma
      Dr. Nair is
      Distinguished
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Bone Tumor
      Dr. Nair is
      Distinguished
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Chromophobe Renal Cell Carcinoma
      Dr. Nair is
      Distinguished
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • Clear Cell Sarcoma
      Dr. Nair is
      Distinguished
      . Learn about Clear Cell Sarcoma.
      See more Clear Cell Sarcoma experts
    • Colorectal Cancer
      Dr. Nair is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    View All 18 Distinguished Conditions
    • Advanced
    • Angiosarcoma
      Dr. Nair is
      Advanced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Cervical Cancer
      Dr. Nair is
      Advanced
      . Learn about Cervical Cancer.
      See more Cervical Cancer experts
    • Dehydration
      Dr. Nair is
      Advanced
      . Learn about Dehydration.
      See more Dehydration experts
    • Endometrial Cancer
      Dr. Nair is
      Advanced
      . Learn about Endometrial Cancer.
      See more Endometrial Cancer experts
    • Epithelioid Sarcoma
      Dr. Nair is
      Advanced
      . Learn about Epithelioid Sarcoma.
      See more Epithelioid Sarcoma experts
    • Familial Prostate Cancer
      Dr. Nair is
      Advanced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    View All 27 Advanced Conditions
    • Experienced
    • Adrenal Cancer
      Dr. Nair is
      Experienced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Nair is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anal Cancer
      Dr. Nair is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Anaplastic Thyroid Cancer
      Dr. Nair is
      Experienced
      . Learn about Anaplastic Thyroid Cancer.
      See more Anaplastic Thyroid Cancer experts
    • Anemia
      Dr. Nair is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Angiosarcoma of the Scalp
      Dr. Nair is
      Experienced
      . Learn about Angiosarcoma of the Scalp.
      See more Angiosarcoma of the Scalp experts
    View All 84 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved